Presentation TCT 2013 Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI Presenter: Subhash Banerjee January 31, 2013 REGISTER for free or LOG IN to view this content CAD Pharma Lipids Presentation TCT 2013 Up Next Presentation TCT 2013 In-Vitro Assessment Of The Influence Of Oval Annuli On The Hydrodynamic Function Of Percutaneous Heart Valve Prostheses Presenter: Maximilian Kuetting January 31, 2013 More slides + Presentation TCT 2013 Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Using a Perfusion Myograph Presenter: Steven Burke January 31, 2013 Presentation TCT 2013 Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting Presenter: Piero Montorsi January 31, 2013 We Recommend
Presentation TCT 2013 In-Vitro Assessment Of The Influence Of Oval Annuli On The Hydrodynamic Function Of Percutaneous Heart Valve Prostheses Presenter: Maximilian Kuetting January 31, 2013
Presentation TCT 2013 Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Using a Perfusion Myograph Presenter: Steven Burke January 31, 2013
Presentation TCT 2013 Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting Presenter: Piero Montorsi January 31, 2013